Apelin-13 induces a biphasic haemodynamic response and hormonal activation in normal conscious sheep

Journal of Endocrinology

Volumn 189, Issue 3, 2006, Pages 701-710

  Charles, Christopher J ^a   Rademaker, Miriam T ^a   Richards, A Mark ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; APELIN 13; ARGIPRESSIN; BRAIN NATRIURETIC PEPTIDE; CORTICOTROPIN; CYCLIC AMP; CYCLIC GMP; HYDROCORTISONE; PEPTIDE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTERIAL PRESSURE; ARTICLE; ATRIOVENTRICULAR BLOCK; CONSCIOUSNESS; CONTROLLED STUDY; DRUG ACTIVITY; ELECTROCARDIOGRAM; HEART ATRIUM PRESSURE; HEART OUTPUT; HEART RATE; HEMODYNAMICS; KIDNEY FUNCTION; NONHUMAN; PRIORITY JOURNAL; SHEEP; VASCULAR RESISTANCE;

ADRENOCORTICOTROPIC HORMONE; ALDOSTERONE; ANIMALS; ARGININE VASOPRESSIN; ATRIAL NATRIURETIC FACTOR; BLOOD PRESSURE; CARDIAC OUTPUT; CYCLIC AMP; CYCLIC GMP; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HEART BLOCK; HEART RATE; HEMODYNAMIC PROCESSES; HOMEOSTASIS; HORMONES; HYDROCORTISONE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; KIDNEY; MODELS, ANIMAL; NATRIURETIC PEPTIDE, BRAIN; SHEEP; STIMULATION, CHEMICAL; VASCULAR RESISTANCE;

EID: 33745232499     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/joe.1.06804     Document Type: Article

References (32)

1. Ashley EA, Powers J, Chen M, Kundu R, Finsterbach T, Caffarelli A, Deng A, Eichorn J, Mahajan R, Agrawal R et al. 2005 The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo. Cardiovascular Research 65 73-82.
2. Berry MF, Pirolli TJ, Jayasankar V, Burdick J, Morine KJ, Gardner TJ & Woo J 2004 Apelin has in vivo inotropic effects on normal and failing hearts. Circulation 110 Suppl II 187-193.
3. Charles CJ, Espiner EA, Cameron VA & Richards AM 1990 Hemodynamic, renal, and endocrine actions of ANF in sheep: effect of 24-h, low-dose infusions. American Journal of Physiology 258 R1279-R1285.
4. Cheng X, Cheng XS & Pang CCY 2003 Venous dilator effect of apelin, an endogenous peptide ligand for the orphan APJ receptor, in conscious rats. European Journal of Pharmacology 470 171-175.
5. De Mota N, Reaux-Le Goazigo A, El Messari S, Chartrel N, Roesch D, Dujardin C, Kordon C, Vaudry H, Moos F & Llorens-Cortes C 2004 Apelin, a potent diuretic neuropeptide counteracting vasopressin actions through inhibition of vasopressin neuron activity and vasopressin release. PNAS 101 10464-10469.
6. Donald RA 1977 Radioimmunoassay of corticotropin (ACTH). In Handbook of Radioimmunoassay, pp 319-390. Ed G Abrahams. New York and Basel: Marcel Dekker.
7. Dunn PJ & Espiner EA 1976 Outpatient screening tests for primary aldosteronism. Australian and New Zealand Journal of Medicine 6 131-135.
8. El Messari S, Iturrioz X, Fassot C, De Mota N, Roesch D & Llorens-Cortes C 2004 Functional dissociation of apelin receptor signaling and endocytosis: implications for the effects of apelin on arterial blood pressure. Journal of Neurochemistry 90 1290-1301.
9. Gardiner SM, March JE, Kemp PA & Bennet T 2004 Bolus injection of human urotensin II in conscious rats evokes a biphasic haemodynamic response. British Journal of Pharmacology 143 422-430.
10. Goldstein DS, Feuerstein G, Izzo JL, Kopin IJ & Keiser HR 1981 Validity and reliability of liquid chromatography with electrochemical detection for measuring plasma levels of norepinephrine and epinephrine in man. Life Sciences 28 267-275.
11. Jaszberenyi M, Bujdoso E & Telegdy G 2004 Behavioural, neuroendocrine and thermoregulatory actions of apelin-13. Neuroscience 129 811-816.
12. Kagiyama S, Fukuhara M, Matsumura K, Lin Y, Fujii K & Iida M 2005 Central and peripheral cardiovascular actions of apelin in conscious rats. Regulatory Peptides 125 55-59.
13. 1)Apelin-13 is a novel radioligand for localizing the APJ orphan receptor in human and rat tissues with evidence for a vasoconstrictor role in man. British Journal of Pharmacology 132 1255-1260.
14. Kawamata Y, Habata Y, Fukusumi S, Hosoya M, Fujii R, Hinuma S, Nishizawa N, Kitada C, Onda H, Nishimura O et al. 2001 Molecular properties of apelin: tissue distribution and receptor binding. Biochimica et Biophysica Acta 1538 162-171.
15. King AJ, Pfeffer JM, Pfeffer MA & Brenner BM 1990 Systemic hemodynamic effects of endothelin in rats. American Journal of Physiology 258 H787-H792.
16. Kleinz MJ, Skepper JN & Davenport AP 2005 Immunocytochemical localisation of the apelin receptor, APJ, to human cardiomyocytes, vascular smooth muscle and endothelial cells. Regulatory Peptides 126 233-240.
17. Lee DK, Cheng R, Nguyen T, Fan T, Kariyawasam AP, Liu Y, Osmond DH, George SR & O'Dowd BF 2000 Characterization of apelin, the ligand for the APJ receptor. Journal of Neurochemistry 74 34-41.
18. Lee DK, Saldivia VR, Nguyen T, Cheng R, George SR & O'Dowd BF 2005 Modification of the terminal residue of apelin-13 antagonizes its hypotensive action. Endocrinology 146 231-236.
19. Lewis JG, Manley L, Whitlow JC & Elder PA 1992 Production of a monoclonal antibody to cortisol: application to a direct immunosorbent assay of plasma. Steroids 57 82-85.
20. Lun S, Espiner EA, Nicholls MG & Yandle TG 1983 A direct radioimmunoassay for aldosterone in plasma. Clinical Chemistry 29 268-271.
21. O'Carroll AM & Lolait SJ 2003 Regulation of rat APJ receptor messenger, ribonucleic acid expression in magnocellular neurons of the paraventricular and supraoptic nuclei by osmotic stimuli. Journal of Neuroendocrinology 15 661-666.
22. O'Carroll AM, Don ALJ & Lolait SJ 2003 APJ receptor mRNA expression in the rat hypothalamic paraventricular nucleus: regulation by stress and glucocorticoids. Journal of Neuroendocrinology 15 1095-1101.
23. Pemberton CJ, Yandle TG, Charles CJ, Rademaker MT, Aitken GD & Espiner EA 1997 Ovine brain natriuretic peptide in cardiac tissues and plasma: effects of cardiac hypertrophy and heart failure on tissue concentration and molecular forms. Journal of Endocrinology 155 541-550.
24. Rademaker MT, Cameron VA, Charles CJ, Espiner EA, Nicholls MG, Pemberton CJ & Richards AM 2000 Neurohormones in an ovine model of compensated postinfarction left ventricular dysfunction. American Journal of Physiology 278 H731-H740.
25. Rademaker MT, Charles CJ, Espiner EA, Fisher S, Frampton CM, Kirkpatrick CMJ, Lainchbury JG, Nicholls MG, Richards AM & Vale WW 2002 Beneficial hemodynamic, endocrine, and renal effects of urocortin in experimental heart failure: comparison with normal sheep. Journal of the American College of Cardiology 40 1495-1505.
26. Reaux A, De Mora N, Skultetyova I, Lenkei Z, El Messari S, Gallatz K, Corvol P, Palkovits M & Llorens-Cortes C 2001 Physiological role of a novel neuropeptide, apelin, and its receptor in the brain. Journal of Neurochemistry 77 1085-1096.
27. Rohmeiss P, Photiadis J, Rohmeiss S & Unger T 1990 Hemodynamic actions of intravenous endothelin in rats: comparison with sodium nitroprusside and methoxamine. American Journal of Physiology 258 H337-H346.
28. Sadler WA, Lynskey C, Gilchrist N, Espiner EA & Nicholls MG 1983 A sensitive radioimmunoassay for measuring plasma antidiuretic hormone. New Zealand Medical Journal 96 959-963.
29. Szokodi I, Tavi P, Foldes G, Voutilainen-Myllyla S, Ilves M, Tokola H, Pikkarainen S, Piuhola J, Rysa J, Toth M et al. 2002 Apelin, the novel endogenous ligand of the orphan receptor APJ, regulates cardiac contractility. Circulation Research 91 434-440.
30. Taheri S, Murphy K, Cohen M, Sujkovic E, Kennedy A, Dhillo W, Dakin C, Sajedi A, Ghatei M & Bloom S 2002 The effects of centrally administered apelin-13 on food intake, water intake and pituitary hormone release in rats. Biochemical and Biophysical Research Communications 291 1208-1212.
31. Tatemoto K, Hosoya M, Habata Y, Fuji R, Kakewaga T, Zou M, Kawamata Y, Fukusumi S, Hinuma S, Kitada C et al. 1998 Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochemical and Biophysical Research Communications 251 471-476.
32. Tatemoto K, Takayama K, Zou M, Zhang W, Kumano K & Fujimiya M 2001 The novel peptide apelin lowers blood pressure via a nitric oxide-dependent mechanism. Regulatory Peptides 99 87-92.